US 2013/0296446 A1Published application

Aqueous ophthalmic composition

AssigneeRohto Pharmaceutical Co., Ltd.

InventorsChinatsu Furumiya, Takayuki Miyano, Atsuko Nakata, Eri Matsumoto

Life of this patent

Estimating the term…

Abstract

This invention relates to an aqueous ophthalmic composition comprising (A) polyoxyethylene castor oil in which the average number of moles of added ethylene oxide is 2 to 12 and (B) terpenoid. According to the present invention, an aqueous ophthalmic composition having an improved foam disappearance speed can be obtained.

Claims8

Dependent claims

An aqueous ophthalmic composition comprising (A) polyoxyethylene castor oil in which the average number of moles of added ethylene oxide is 2 to 12 and (B) terpenoid.

Dependencies are inferred from the claim text.

Facts

Application: 13/995,893Filed 27 Dec 2011
Priority: JP 2010-29244128 Dec 2010
Published: 7 Nov 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 47/44
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents…: oils,…
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears
A61K 9/08
Medicinal preparations characterised by special physical form: solutions
A61K 47/02
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents…:…

Family

US 9,034,931 B2Related patent
US 2013/0296446 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results